ConductScience.org, home

Paper39339271

Analysis of Lipophilicity and Pharmacokinetic Parameters of Dipyridothiazine Dimers with Anticancer Potency.

Martula E and 3 others. Pharmaceutics, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Analysis of Lipophilicity and Pharmacokinetic Parameters of Dipyridothiazine Dimers with Anticancer Potency. Papers, record 39339271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39339271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Analysis of Lipophilicity and Pharmacokinetic Parameters of Dipyridothiazine Dimers with Anticancer Potency.
PubMed
Journal
Pharmaceutics
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.71, provisional
iCite
Revised in PubMed
2024-09-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Martula EEmiliahttps://orcid.org/0000-0003-3614-5247
2Morak-Młodawska BBeatahttps://orcid.org/0000-0001-5389-1079
3Jeleń MMałgorzatahttps://orcid.org/0000-0002-4144-990X
4Okechukwu PNPatrick Nwabuezehttps://orcid.org/0000-0002-3855-2666

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
BNW-2-051/K/4/FMedical University of SilesiaPubMed

Source PubMed

Download CSV of grants

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112546556Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.J Chem Inf Comput Sci2003https://conductscience.org/library/papers/12546556PubMed
238005384Synthesis and Structural Characterization of Novel Dimers of Dipyridothiazine as Promising Antiproliferative Agents.Molecules2023https://conductscience.org/library/papers/38005384PubMed
312826129Profiling drug-like properties in discovery research.Curr Opin Chem Biol2003https://conductscience.org/library/papers/12826129PubMed
412745926Neither lipophilicity nor membrane-perturbing potency of phenothiazine maleates correlate with the ability to inhibit P-glycoprotein transport activity.Mol Membr Biol2003https://conductscience.org/library/papers/12745926PubMed
534463935Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles.Pharm Res2021https://conductscience.org/library/papers/34463935PubMed
631736369Is there enough focus on lipophilicity in drug discovery?Expert Opin Drug Discov2020https://conductscience.org/library/papers/31736369PubMed
711259830Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv Drug Deliv Rev2001https://conductscience.org/library/papers/11259830PubMed
830799643Lipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies.Future Med Chem2019https://conductscience.org/library/papers/30799643PubMed
911911703Predicting Caco-2 cell permeation coefficients of organic molecules using membrane-interaction QSAR analysis.J Chem Inf Comput Sci2002https://conductscience.org/library/papers/11911703PubMed
109879505Multivariate analysis of experimental and computational descriptors of molecular lipophilicity.J Comput Aided Mol Des1998https://conductscience.org/library/papers/9879505PubMed
1130070363Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches - a PEARRL review.J Pharm Pharmacol2019https://conductscience.org/library/papers/30070363PubMed
1236677832Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments.Molecules2023https://conductscience.org/library/papers/36677832PubMed
1337108135Study of Lipophilicity and ADME Properties of 1,9-Diazaphenothiazines with Anticancer Action.Int J Mol Sci2023https://conductscience.org/library/papers/37108135PubMed
1429589935Lipophilic Efficiency as an Important Metric in Drug Design.J Med Chem2018https://conductscience.org/library/papers/29589935PubMed
1524468238Rapid determination of octanol-water partition coefficient using vortex-assisted liquid-liquid microextraction.J Chromatogr A2014https://conductscience.org/library/papers/24468238PubMed
1624464959Heterocycles 33: lipophilicity of a new class of thioethers estimated by reversed-phase thin-layer chromatography and different computational methods.J Chromatogr Sci2014https://conductscience.org/library/papers/24464959PubMed
1730320896Lipidic prodrug approach for improved oral drug delivery and therapy.Med Res Rev2019https://conductscience.org/library/papers/30320896PubMed
1830040971Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski's Rule of Five.Int J Pharm2018https://conductscience.org/library/papers/30040971PubMed
1933679401Advances in Oral Drug Delivery.Front Pharmacol2021https://conductscience.org/library/papers/33679401PubMed
2030039409The Impact of Lipophilicity in Drug Discovery: Rapid Measurements by Means of Reversed-Phase HPLC.Methods Mol Biol2018https://conductscience.org/library/papers/30039409PubMed

See all 24 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42883808Comparative RP-HPTLC Lipophilicity Analysis of Bioactive 1,3,4-Thiadiazole-Resorcinol Conjugates.Int J Mol Sci2026https://conductscience.org/library/papers/42883808PubMed
41011127Use of TLC and Computational Methods to Determine Lipophilicity Parameters of Selected Neuroleptics: Comparison of Experimental and Theoretical Studies.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41011127PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39339271

GET https://conductscience.org/api/papers/v1/39339271/references?page=2